Login or sign up
For business
Average ratingAverage
3.9/ 5

Based on 10 reviews

530%
430%
340%
20%
10%
Ask AI

Questions about Bioxodes

Based on 10 reviews, listing data and website checks · updated 6 days ago

What is Bioxodes?

Bioxodes is a clinical-stage biopharmaceutical company based in Gosselies, Belgium, dedicated to developing novel therapeutics to prevent thrombotic events without hemorrhagic risk. Their lead candidate, BIOX-101, targets intracerebral hemorrhage (ICH) and ischemic stroke by inhibiting neutrophil activation and coagulation factors FXIIa and FXIa. The company has received Orphan Drug Designation in Europe and the U.S. for ICH and is preparing a Phase 2b trial following encouraging Phase 2a results.

What makes BIOX-101 different from other treatments?

The company's lead asset, BIOX-101, is a recombinant version of a small protein found in the saliva of the tick Ixodes ricinus. This dual-mode mechanism reflects the tick's natural ability to attach to hosts without detection (anti-inflammation) and feed on blood (anticoagulation), aiming to prevent secondary damage in ICH.

What do preclinical studies say about BIOX-101's effects?

According to a preclinical study published in CNS Neuroscience & Therapeutics, Ir-CPI (BIOX-101) demonstrated beneficial effects in a mouse model of ICH, including preserved hemorrhagic stability and reduced neuroinflammation. The study showed that treatment significantly reduced neutrophil infiltration and neutrophil extracellular trap (NET) formation in specific brain regions.

What are the current clinical trial stages for BIOX-101?

Bioxodes is currently preparing BIOX-101 for a Phase 2b trial in ischemic stroke, having already completed a Phase 2a trial. The company is also developing a pipeline of drug candidates to treat chronic thrombo-inflammatory and inflammatory diseases beyond stroke.

Where is Bioxodes located and what industry does it belong to?

The company is located at Parc d'activités Aéropole, Rue Santos-Dumont, 1, 6041 Gosselies, Belgium, within the Brussels South Charleroi Biopark. They operate in the biotechnology industry and focus on thrombo-inflammation at its source.

What do reviewers praise about Bioxodes?

Some reviewers on Trustburn praise Bioxodes for exceptional customer service and top-notch product quality. Users frequently mention that the supplements have made a noticeable difference in their overall well-being and have helped them overcome health issues.

How long has Bioxodes been in operation?

Bioxodes has been operating since at least 2021, as indicated by the copyright date on their website. They have a presence on LinkedIn and use tools like Google Analytics to track web traffic and improve their site's effectiveness.

How can potential customers contact Bioxodes?

The company can be contacted via the business phone number +32 (0)71 239 600 or the email address info@bioxodes.com. They also maintain a website at bioxodes.com for further information.

Which markets and countries does Bioxodes serve?

Bioxodes serves markets in Europe and the U.S., as evidenced by their Orphan Drug Designation in these regions. They are developing therapies for conditions like intracerebral hemorrhage and ischemic stroke, which are significant unmet medical needs.

What should a first-time customer know about BIOX-101?

A first-time customer should know that BIOX-101 is designed to inhibit the activation of neutrophils and the release of neutrophil extracellular traps (NETs). This dual action aims to prevent secondary damage in ICH while exerting a powerful anticoagulant effect without increasing bleeding risk.

What do news articles say about BIOX-101's clinical data?

News articles report that BIOX-101 showed a statistically significant reduction in perihematomal edema growth in intracerebral hemorrhage. At the World Stroke Congress, new imaging analyses and one-year functional outcome data were presented, showing a lower change in normalized hemorrhage volume compared to standard of care.

What specific features or mechanisms does BIOX-101 utilize?

Bioxodes leverages the unique mechanism of action of BIOX-101 on neutrophils and coagulation factors FXIIa and FXIa. This approach is described as a breakthrough for hemorrhagic stroke patients, aiming to deliver breakthrough therapies by developing an innovative pipeline in thrombo-inflammation.

What is the official website of Bioxodes?

The official website of Bioxodes is bioxodes.com.

How is Bioxodes rated on Trustburn?

On Trustburn, Bioxodes has a rating of 3.9 out of 5 based on 10 reviews.

Is Bioxodes on social media?

Bioxodes has official profiles on Linkedin.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Bioxodes

Bioxodes is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics to prevent thrombotic events without hemorrhagic risk.

Categories
Biotechnology